Pharmaceutical compositions comprising anti-human TSLP receptor antibodies and methods of using the same
US12150991B2 · kind B2 · utility
0Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2023 |
| Grant date | Nov 26, 2024 |
| Priority date | — |
| Expiry date | Nov 7, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical compositions of anti-TSLP-R antibodies, and uses thereof, are provided herein. The pharmaceutical compositions can comprise for example, an anti-TSLP-R antibody, or antigen-binding fragment thereof, a pharmaceutically acceptable buffer, an excipient, and a surfactant, or other compositions as provided for herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.